LBL-003

· Nanjing Leads Biolabs Co.,Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LBL-003, covering 2024-05-21 to 2024-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies [Phase 1]